Compare ARK Genomic Revolution ETF (ARKG) vs Marathon Petroleum Corp (MPC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Marathon Petroleum Corp — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while Marathon Petroleum Corp trades at $288 (market cap $82.83B). The key difference: Marathon Petroleum Corp pays a 1.38% dividend while ARK Genomic Revolution ETF pays none, and Marathon Petroleum Corp is trading nearer its 52-week high, ARK Genomic Revolution ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | MPC | |
|---|---|---|
Sector | Sector/Thematic | Energy |
52-Week High | $43.57 | $283.74 |
52-Week Low | $23.09 | $158.59 |
Market Cap | — | $82.83B |
Enterprise Value | — | $115.01B |
Dividend Yield | — | 1.38% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Marathon Petroleum (MPC) trades at $283.74, up 0.16% with a bullish technical outlook supported by moving averages. The stock shows strong profitability with 27.92% ROE and attractive valuation metrics including P/E of 18.68 and P/S of 0.63. Recent earnings beat expectations in Q4 2025 and Q1 2026, while refining capacity constraints and Middle East tensions provide tailwinds for the energy sector.
MPC presents a compelling value opportunity with solid fundamentals and positive analyst sentiment, though investors face risks from volatile oil prices, regulatory scrutiny over pricing practices, and declining revenue trends. The stock trades near analyst consensus target of $278.38 with 76% buy ratings supporting upside potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Marathon Petroleum Corp
Marathon Petroleum is an independent refiner with 13 refineries in the midcontinent, West Coast, and Gulf Coast of the United States with total throughput capacity of 2.9 million barrels per day. Its Dickinson, ND, facility produces 184 million gallons a year of renewable diesel. Its Martinez, CA, facility will have the ability to produce 730 million gallons a year of renewable diesel once converted. The firm also owns and operates midstream assets primarily through its listed MLP, MPLX.
Read more on MPC →
